Loading organizations...
Loading organizations...
Biotechnology company innovating ADC therapeutics with dual linker technolo
CrossBridge Bio has raised $25.0M across 2 funding rounds.
CrossBridge Bio has raised $25.0M in total across 2 funding rounds.
CrossBridge Bio has raised $25.0M in total across 2 funding rounds.
CrossBridge Bio's investors include Cancer Prevention and Research Institute of Texas, Crescent Enterprises, William McKeon, Alexandria Venture Investments, Linden Lake Labs, Portal Innovations.
CrossBridge Bio has raised $25.0M across 2 funding rounds. Most recently, it raised $15.0M Grant in November 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 20, 2025 | $15.0M Grant | Cancer Prevention and Research Institute of Texas | |
| Nov 4, 2024 | $10.0M Seed | Crescent Enterprises, William McKeon | Alexandria Venture Investments, Linden Lake Labs, Portal Innovations |